BIONICS Israel Trial

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

January 16, 2017

Study Completion Date

December 16, 2017

Conditions
Stenosis
Interventions
DEVICE

BioNIR Ridaforolimus Eluting Coronary Stent System

BioNIR Ridaforolimus eluting coronary stent system with modified delivery system

Trial Locations (1)

Unknown

Sourasky Medical Center, Tel Aviv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medinol Ltd.

INDUSTRY

NCT02834806 - BIONICS Israel Trial | Biotech Hunter | Biotech Hunter